Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4556367
Max Phase: Preclinical
Molecular Formula: C19H20ClNO
Molecular Weight: 313.83
Molecule Type: Unknown
Associated Items:
ID: ALA4556367
Max Phase: Preclinical
Molecular Formula: C19H20ClNO
Molecular Weight: 313.83
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCc1ccc(-c2ccc(Cl)cc2)cc1)N1CCCC1
Standard InChI: InChI=1S/C19H20ClNO/c20-18-10-8-17(9-11-18)16-6-3-15(4-7-16)5-12-19(22)21-13-1-2-14-21/h3-4,6-11H,1-2,5,12-14H2
Standard InChI Key: KIEHFPQELRPEOU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 313.83 | Molecular Weight (Monoisotopic): 313.1233 | AlogP: 4.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.35 | CX LogD: 4.35 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -0.92 |
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |
Source(1):